• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Go sign green light
Biotech

FDA reconsidering Capricor’s snubbed DMD cell therapy

The agency has “lifted” the rejection letter for deramiocel, the company said, with a new decision expected by Aug. 22.
Darren Incorvaia Mar 10, 2026 11:14am
Ugur Sahin

BioNTech's CEO, CMO will depart to set up next-gen mRNA company

Mar 10, 2026 6:30am
How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society
The Capitol Building in Washington DC with bright blue sky - stock photo Becky WrightGetty Images

‘Bureaucratic idiocy’: GOP senator to investigate FDA rejections

Mar 10, 2026 11:10am
An abstract image of data

ARPA-H kicks off wearable biosensor development program

Mar 10, 2026 1:59pm
no longer in business sign

Molecular glue biotech f5 Therapeutics closes down

Mar 10, 2026 1:10pm
More News

Lilly pledges $500M to South Korea biopharma industry

Mar 10, 2026 12:00pm

Fierce Biotech Layoff Tracker 2026: f5 Tx, Vertex & more

Mar 10, 2026 11:00am

Medtronic to drop $550M for Scientia and its stroke care catalog

Mar 10, 2026 10:34am

Voyager pauses Alzheimer's program 8 months after unveiling med

Mar 10, 2026 10:20am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings